1557268-88-8 Usage
General Description
N-(3-((2-((3-Fluoro-4-(4-methylpiperazin-1-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenyl)acrylamide maleate is a chemical compound that is characterized by the presence of fluorine, nitrogen, oxygen, phenyl, and acrylamide groups in its structure. This complexity suggests its possible synthesis in a laboratory setting and potential use in various scientific applications, which might include drug development given its molecular complexity. The descriptive name indicates its chemical structure and every component and bond in it. However, exact properties, toxicology, and specific usage of this chemical compound would have to be determined based on additional specific studies.
Check Digit Verification of cas no
The CAS Registry Mumber 1557268-88-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,5,7,2,6 and 8 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1557268-88:
(9*1)+(8*5)+(7*5)+(6*7)+(5*2)+(4*6)+(3*8)+(2*8)+(1*8)=208
208 % 10 = 8
So 1557268-88-8 is a valid CAS Registry Number.
1557268-88-8Relevant articles and documents
PHARMACEUTICAL SALTS, PHYSICAL FORMS, AND COMPOSITIONS OF PYRROLOPYRIMIDINE KINASE INHIBITORS, AND METHODS OF MAKING SAME
-
, (2019/04/26)
The present invention relates to methods of making certain pyrrolopyrimidine derivatives, which are useful in the treatment of proliferation disorders and other diseases related to the dysregulation of kinase (such as, but not limited to, EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, BTK, FLT3(D835Y), ITK, JAK1, JAK2, JAK3, TEC and TXK) and/or the respective pathways, salts, polymorphs, and amorphous forms of said compounds, synthetic intermediates for preparing said compounds, and pharmaceutical compositions comprising said compounds and methods for making such compositions.
NOVEL EGFR MODULATORS AND USES THEREOF
-
Paragraph 0632; 0633, (2014/02/16)
The present invention relates to certain pyrrolopyrimidine derivatives, pharmaceutical compositions containing them, and methods of using them, including methods for the treatment of tumors and related diseases related to the dysregulation of kinase (such